A point-of-care test (POCT) is a test that can be performed outside of a laboratory setting for which the result is available without reference to a laboratory and rapid enough to affect immediate patient management (1). Most POCT for syphilis are available with a short turn-around time with test results available in ≤20 min (2). For developing countries, the tests should be affordable, sensitive, specific, user friendly or simple to perform with minimal training, rapid, robust (ie, stable and not requiring cold-chain storage conditions), equipment-free and delivered to those who need it (www.who.int/std_diagnostics/about_SDI/priorities.htm).
Over the past several years, Canada has experienced syphilis outbreaks in street-involved persons, bathhouses and drop-in centres which are traditionally hard to reach through standard services. POCT would provide the ability to offer immediate testing and treatment in a single encounter to mitigate further spread, and an attractive alternative to standard testing (9, 10) .
Currently, there are no POCT approved for the diagnosis of syphilis in Canada. The majority of commercially available POCT are based on treponemal antigens. These tests cannot distinguish previously treated infections from untreated syphilis (11) . Management based on treponemal antigen based POCT may result in unnecessary administration of antibiotics to patients and may also be psychologically detrimental to patients due to the stigma of a STI diagnosis (10) . However, in hard-to-reach populations, the benefit of POCT could potentially outweigh the risks. Recognizing this trade-off, the U.S. Centers for Disease Control and Prevention recommends rapid screening and treatment for patients having positive tests at the first prenatal visit in populations in which use of "prenatal care is not optimal" (12) . The United States FDA announced approval of a rapid syphilis test in September, 2011 (13) . Syphilis POCT may provide 'while you wait' test results which can be confirmed by a non-treponemal test to identify high-risk patients for improved follow-up. 
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TYPES OF POCTS a) Treponemal tests
Currently (Table 1) there are several commercial tests available internationally (10). They are of two varieties: 1) immunochromatographic strip (ICS) tests which work by having a test strip with a line that is impregnated with treponemal antigens that react with antibodies to syphilis in whole blood or serum to produce a readable change on the test strip; 2) particle agglutination tests (PATs), which use gelatin particles coated with treponemal antigens that clump together on a test tray when combined with whole blood or serum containing antibodies to syphilis. The Sexually Transmitted Diseases Diagnostics Initiative (SDI) conducted laboratory based evaluations on seven POCT (11) . Tables 2  and 3 summarize the use of POCT in antenatal and other clinical settings. Although some of the studies reported low sensitivity values, the median sensitivity was 86% (interquartile range [IQR] 75% to 94%) and was comparable between antenatal and non-antenatal clinic sites. Two studies showed better sensitivity when serum specimens were used (11, 14) . Specificities ranged from 91% to 100% for studies with similar medians of 99% (IQR 97% to 100%) in all settings. The POCT also showed good positive predictive values of >80% when syphilis prevalence was >0.3%. Limited data are available to confirm if the sensitivity is maintained in HIV-infected individuals (15) and in those with high RPR titres (15, 16 ). An Australian laboratory based study of four syphilis POCT reported that the Determine test had the highest overall sensitivity with significantly higher test sensitivities among high-RPR titre (RPR ≥ 1:8) tests (17) .
Only one test, the Syphilis Health Check (Trinity Biotech, USA), is United States FDA approved for use in the United States (18) . This 10 min test can be used with whole blood, serum or plasma specimens, requires 25 μL to 50 μL of blood. According to the manufacturer, this treponemal POC test for syphilis has a reported 95.6% positive agreement and a 90.5% negative agreement with gold-standard testing, with a percent overall agreement of 90.6% (19) . No published clinical data on test performance are available.
In the only published study of syphilis POCT in Canada, Bergman et al (20) reported a sensitivity of 85.3% (CI 68.9% to 95.0%), specificity of 100.0% (CI (99.6% to 100.0%), positive predictive value (PPV) of 100.0% (CI 88.1% to 100.0), and negative predictive value (NPV) of 99.5% (CI 98.9% to 99.8%) of the SD Bioline 3.0 Syphilis Test (Standard Diagnostics, Korea) in hard-to-reach outreach settings in Edmonton, Alberta (20) .
Available data on the antenatal cost-effectiveness of RPOCT show that the ICS TT tests are cost-effective for the detection of maternal syphilis in low resource settings when compared to either standard twotest testing algorithms (ie, NTT followed by TT) or a NTT alone (21) (22) (23) . Owusu-Edusei et al (24) recently reported that a screening strategy employing an ICS TT was more cost saving than a dual-RPOCT (TT for the simultaneous detection of non-treponemal and treponemal antibodies in sera of 1601 patients. Results from the dual test were compared with rapid plasma reagin (RPR) and Treponema pallidum particle agglutination (TPPA) tests. When compared with the RPR, the reactive concordance of the non-treponemal result was 98.4% when the RPR was ≥1:2. However, when the RPR was ≤1, the sensitivity declined to 88%. When compared to the TPPA, the reactive and non-reactive concordance of the treponemal line was 96.5% and 95.5%. This dual POCT is designed for use with serum, plasma and whole blood. Span Diagnostics (India) also makes a dual test (www.span.co.in/#) but no published data on its performance in the field are available.
DIFFICULTIES ENCOUNTERED wITH POCT
Choice of test kit and specimen type are important when deciding which kit will perform optimally in any given field setting. For example, Campos et al (26) reported lower sensitivities with whole blood (fingerprick) specimens which might have been due to inadequate lighting, lack of use of heparinized capillary tubes for collection of whole blood, false negatives due to previously treated syphilis and a low proportion of samples reactive at low titres. Herring et al (11) showed variability between test lots, day to day testing and differences between testers. Because POCT are often performed by inexperienced nonlaboratorians outside of a laboratory, results can be variable. Judgment is used on subjective interpretation of a band being positive or negative in an ICS or agglutination strength in a PAT. Sufficient lighting should be provided to read results.
Programs may wish to develop procedural manuals in conjunction with a local reference laboratory to include a control and proficiency testing program. This is to ensure the competence of the testing staff as well as the integrity of the testing materials.
Some components of the QA program could include photographs of positive and negative reactions, the running of positive and negative controls, eg, with each new box of kits that is opened; the results should be recorded and logged. Storage conditions for the kits should be specified with logs kept for temperature control and logs kept as well as procedures developed to respond to incidents, eg, actions for invalid tests, parallel testing discrepancy and control failure.
USE OF POCT FOR THE DIAGNOSIS OF SYPHILIS
It should be noted that similar to other screening tests for syphilis, a single POCT for syphilis may not be adequate for the diagnosis of syphilis and should follow recommended testing algorithms as described in the Chapter on Serologic Testing for Syphilis.
SUMMARY
Although not yet licensed or routinely available in Canada, syphilis POCT have the potential to provide immediate and rapid access to testing and therefore treatment in 'hard-to-reach populations' or in non-traditional venues to mitigate the spread of syphilis. POCT which employ treponemal tests are also most likely to be of benefit in areas with high prevalence of new syphilis infections together with low rates of previous infection with syphilis. Further studies are needed to evaluate the utility, acceptance, effectiveness, quality control/quality assurance, potential adverse events and cost-effectiveness of syphilis POCT in clinics and field-based settings. Laboratories and clinicians should ensure the development of effective algorithms to confirm cases as well as maintain acceptable quality of POCT.
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